W. Baccaglini

The cost of intensification in high-risk non–muscle-invasive bladder cancer

Non–muscle-invasive bladder cancer (NMIBC) is a common and costly disease that requires experienced teams and adequate infrastructure for its management. Although characterized by high rates of recurrence, a subset of patients also faces a substantial risk of progression to muscl...